EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
-2.54%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$969M
AUM Growth
+$969M
(-26%)
Cap. Flow
-$232M
Cap. Flow
% of AUM
-23.92%
Top 10 Holdings %
Top 10 Hldgs %
64.29%
Holding
82
New
14
Increased
14
Reduced
29
Closed
17
Top Buys
| 1 |
HCA Healthcare
HCA
|
$14M |
| 2 |
Bruker
BRKR
|
$13.8M |
| 3 |
Edwards Lifesciences
EW
|
$12.6M |
| 4 |
DexCom
DXCM
|
$11.6M |
| 5 |
Teleflex
TFX
|
$11M |
Top Sells
| 1 |
Insmed
INSM
|
$79.5M |
| 2 |
Syndax Pharmaceuticals
SNDX
|
$49.7M |
| 3 |
United Therapeutics
UTHR
|
$30.8M |
| 4 |
Bio-Techne
TECH
|
$26.2M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$21.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Natera
NTRA
$23.1B
| $139M | 12.32% | 876,766 +6,573 | +0.8% | +$1.04M |
|
2
GSK
GSK
$79.9B
| $124M | 10.99% | 3,661,768 -395,438 | -10% | -$13.4M |
|
3
Vera Therapeutics
VERA
$1.38B
| $67.7M | 6.01% | 1,600,015 -450,142 | -22% | -$19M |
|
4
Inspire Medical Systems
INSP
$2.77B
| $54.6M | 4.84% | 294,302 +18,032 | +7% | +$3.34M |
|
|
5
HCA Healthcare
HCA
$94.5B
| $52.8M | 4.68% | 175,808 +46,724 | +36% | +$14M |
|
|
6
Teva Pharmaceuticals
TEVA
$21.1B
| $49.4M | 4.39% | 2,242,125 -992,513 | -31% | -$21.9M |
|
7
Revvity
RVTY
$10.5B
| $43.8M | 3.89% | 392,518 -77,174 | -16% | -$8.61M |
|
8
HealthEquity
HQY
$7.72B
| $37.1M | 3.29% | 386,697 +67,619 | +21% | +$6.49M |
|
9
ZimVie
ZIMV
$532M
| $28.9M | 2.56% | 2,070,780 | – | – |
|
10
Protagonist Therapeutics
PTGX
$3.67B
| $26.2M | 2.33% | 678,787 +233,583 | +52% | +$9.02M |
|
|
11
Bio-Techne
TECH
$8.5B
| $21.6M | 1.91% | 299,310 -364,263 | -55% | -$26.2M |
|
12
Celldex Therapeutics
CLDX
$1.47B
| $18.2M | 1.61% | 719,836 +154,934 | +27% | +$3.92M |
|
13
Viatris
VTRS
$12.3B
| $15.8M | 1.41% | 1,272,102 -454,252 | -26% | -$5.66M |
|
|
14
United Therapeutics
UTHR
$13.8B
| $15.4M | 1.37% | 43,703 -87,246 | -67% | -$30.8M |
|
15
Viridian Therapeutics
VRDN
$1.5B
| $15M | 1.33% | 779,998 +88,766 | +13% | +$1.7M |
|
16
BioCryst Pharmaceuticals
BCRX
$1.74B
| $14.9M | 1.32% | 1,980,312 +1,444,907 | +270% | +$10.9M |
|
|
17
Bruker
BRKR
$5.16B
| $13.8M | 1.22% | +234,934 | New | +$13.8M |
|
|
18
Edwards Lifesciences
EW
$47.8B
| $12.6M | 1.12% | +170,678 | New | +$12.6M |
|
|
19
DexCom
DXCM
$29.5B
| $11.6M | 1.03% | +148,688 | New | +$11.6M |
|
20
Centene
CNC
$14.3B
| $11.4M | 1.01% | 188,493 +53,534 | +40% | +$3.24M |
|
|
21
Teleflex
TFX
$5.59B
| $11M | 0.98% | +61,736 | New | +$11M |
|
22
Elevance Health
ELV
$71.8B
| $10.8M | 0.96% | 29,178 +9,713 | +50% | +$3.58M |
|
23
Vaxcyte
PCVX
$4B
| $10.4M | 0.93% | +127,588 | New | +$10.4M |
|
24
Travere Therapeutics
TVTX
$1.56B
| $8.54M | 0.76% | 490,296 -379,617 | -44% | -$6.61M |
|
25
Community Health Systems
CYH
$387M
| $8.45M | 0.75% | 2,827,000 -5,949,455 | -68% | -$17.8M |
|